Axsome Therapeutics, Inc (AXSM) stock analysis and AI prediction
The company facts of Axsome Therapeutics, Inc, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Axsome Therapeutics, Inc
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $7.6 billion
- Size
- Mid cap
- Employees
- 925
- Headquarters
- NEW YORK, NY
- Listed since
- Nov. 19, 2015
- Website
- axsome.com
More Healthcare stocks
Other mid cap stocks
Keep going
AXSM questions
What is the AI prediction for AXSM stock?
Each market day our model rates Axsome Therapeutics, Inc (AXSM) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the AXSM prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for AXSM?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see AXSM options?
The AXSM options page opens its calls and puts, with price, volume, implied volatility and the Greeks.